AJO LP’s Blueprint Medicines BPMC Stock Holding History

AJO LP’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,185	Closed	-$821K	–	586
2019 Q3	$821K	Sell	11,185 -464	-4%	-$40.1K	﹤0.01%	463
2019 Q2	$1.1M	Buy	+11,649	New	+$961K	0.01%	466

Other funds holding BPMC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

AJO LP's BPMC Position: Q4 2019 in Review

AJO LP sold out of Blueprint Medicines (BPMC) in Q4 2019, closing a stake of 11,185 shares — an estimated $821K sold.

AJO LP first reported a position in BPMC in Q2 2019 and held it in 2 quarters. The position peaked at $1.1M in Q2 2019. 227 funds tracked by Wall St. Rank hold BPMC as of Q4 2019.

AJO LP reported no remaining Blueprint Medicines position as of Q4 2019 after selling out during the quarter.
AJO LP sold 11,185 Blueprint Medicines shares in Q4 2019, an estimated $821K.
AJO LP first reported a position in Blueprint Medicines in Q2 2019 and held it in 2 quarters.
AJO LP's Blueprint Medicines position peaked at $1.1M in Q2 2019.
227 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2019.

Based on AJO LP's 13F filing for Q4 2019, filed 12 Feb 2020.